Defining screening for psoriatic arthritis and measurement of psoriatic arthritis symptoms in psoriasis clinical trials: An international Delphi survey - 22/08/19
Lourdes Maria Perez-Chada, MD, MMSc, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Alice Bendix Gottlieb, MD, PhD, Icahn School of Medicine at Mt Sinai, New York, NY; Jeffrey Cohen, MD, New York University School of Medicine, New York, NY; Philip Mease, MD, Swedish Medical Center/Providence St. Joseph Health and University of Washington School of Medicine, Seattle, WA; Kristina Callis Duffin, MD, MS, University of Utah, Salt Lake City, UT; Amit Garg, MD, Hofstra Northwell School of Medicine, New Hyde Park, NY; John Latella, BS, International Dermatology Outcome Measures (IDEOM), Windsor, CT; April Wang Armstrong, MD, MPH, University of Southern California Keck School of Medicine, Los Angeles, CA; Alexis Ogdie, MD, MSE, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Joseph Frank Merola, MD, MMSc, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Le texte complet de cet article est disponible en PDF.| Commercial support: None identified. |
Vol 81 - N° 4S1
P. AB42 - octobre 2019 Retour au numéro
Article précédent
- Defining normal forehead height across sex, age and race: A pilot study
- Dermatitis chronica athropicans secondary to Borrelia afzelii infection locally acquired in Northern Mexico
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?